Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T23:24:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T20:33:52.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Several key resources related to ovarian cancer and clinical trials have been removed, including links to MedlinePlus and DailyMed, which may impact access to important information on treatments and studies.
    Difference
    3%
    Check dated 2024-11-23T05:54:59.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    New resources related to ovarian cancer, including clinical trial documents and drug information, have been added, enhancing the available information on this condition.
    Difference
    1%
    Check dated 2024-11-16T01:24:30.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, adding new features for downloading data in various formats and allowing users to select specific fields for export.
    Difference
    3%
    Check dated 2024-11-08T19:08:25.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.6%
    Check dated 2024-11-01T11:40:56.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.